Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    15894097 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Palbociclib / Letrozole in African American Women With HR+ HER2- Breast Cancer
Condition: Hormone Receptor Positive HER-2 Negative Breast Cancer
Intervention: Drug: Palbociclib + Letrozole
2 Completed Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy
Condition: Breast Cancer
Intervention: Drug: Anastrozole
3 Recruiting TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Intraoperative radiotherapy (IORT)

Study has passed its completion date and status has not been verified in more than two years.